Letter to the editor in re: Mohan et al., 2020 ‘dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels’

Bibliographic Details
Main Authors:	E.H. Romach, L.M. Posobiec, J.C. Bloomer, M.J. Zamek-Gliszczynski, D.J. Stanislaus
Format:	Article
Language:	English
Published:	Elsevier 2021-04-01
Series:	EBioMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396421001286

id	doaj-0f4acf88341e46c0900025dc7a4b6c4f
record_format	Article
spelling	doaj-0f4acf88341e46c0900025dc7a4b6c4f2021-04-30T07:22:54ZengElsevierEBioMedicine2352-39642021-04-0166103335Letter to the editor in re: Mohan et al., 2020 ‘dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels’E.H. Romach0L.M. Posobiec1J.C. Bloomer2M.J. Zamek-Gliszczynski3D.J. Stanislaus4Viiv Healthcare, RTP, NC, USA; Corresponding author.GlaxoSmithKline, Collegeville, PA, USAGlaxoSmithKline, Ware, UKGlaxoSmithKline, Collegeville, PA, USAGlaxoSmithKline, Collegeville, PA, USAhttp://www.sciencedirect.com/science/article/pii/S2352396421001286
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	E.H. Romach L.M. Posobiec J.C. Bloomer M.J. Zamek-Gliszczynski D.J. Stanislaus
spellingShingle	E.H. Romach L.M. Posobiec J.C. Bloomer M.J. Zamek-Gliszczynski D.J. Stanislaus Letter to the editor in re: Mohan et al., 2020 ‘dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels’ EBioMedicine
author_facet	E.H. Romach L.M. Posobiec J.C. Bloomer M.J. Zamek-Gliszczynski D.J. Stanislaus
author_sort	E.H. Romach
title	Letter to the editor in re: Mohan et al., 2020 ‘dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels’
title_short	Letter to the editor in re: Mohan et al., 2020 ‘dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels’
title_full	Letter to the editor in re: Mohan et al., 2020 ‘dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels’
title_fullStr	Letter to the editor in re: Mohan et al., 2020 ‘dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels’
title_full_unstemmed	Letter to the editor in re: Mohan et al., 2020 ‘dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels’
title_sort	letter to the editor in re: mohan et al., 2020 ‘dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels’
publisher	Elsevier
series	EBioMedicine
issn	2352-3964
publishDate	2021-04-01
url	http://www.sciencedirect.com/science/article/pii/S2352396421001286
work_keys_str_mv	AT ehromach lettertotheeditorinremohanetal2020dolutegravirinpregnantmiceisassociatedwithincreasedratesoffetaldefectsattherapeuticbutnotatsupratherapeuticlevels AT lmposobiec lettertotheeditorinremohanetal2020dolutegravirinpregnantmiceisassociatedwithincreasedratesoffetaldefectsattherapeuticbutnotatsupratherapeuticlevels AT jcbloomer lettertotheeditorinremohanetal2020dolutegravirinpregnantmiceisassociatedwithincreasedratesoffetaldefectsattherapeuticbutnotatsupratherapeuticlevels AT mjzamekgliszczynski lettertotheeditorinremohanetal2020dolutegravirinpregnantmiceisassociatedwithincreasedratesoffetaldefectsattherapeuticbutnotatsupratherapeuticlevels AT djstanislaus lettertotheeditorinremohanetal2020dolutegravirinpregnantmiceisassociatedwithincreasedratesoffetaldefectsattherapeuticbutnotatsupratherapeuticlevels
_version_	1721498558511710208

Letter to the editor in re: Mohan et al., 2020 ‘dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels’

Similar Items